-
Signature
-
/s/ Adam N. King, Attorney-in-Fact
-
Issuer symbol
-
IPGP
-
Transactions as of
-
29 Jan 2024
-
Net transactions value
-
-$51,700
-
Form type
-
4
-
Filing time
-
31 Jan 2024, 16:08:47 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IPGP |
Common Stock |
Options Exercise |
$51,544 |
+813 |
+4.9% |
$63.40 |
17,304 |
29 Jan 2024 |
Direct |
|
| transaction |
IPGP |
Common Stock |
Sale |
$64,623 |
-657 |
-3.8% |
$98.36 |
16,647 |
29 Jan 2024 |
Direct |
F1, F2 |
| transaction |
IPGP |
Common Stock |
Sale |
$15,600 |
-156 |
-0.94% |
$100.00 |
16,491 |
29 Jan 2024 |
Direct |
F1, F3 |
| transaction |
IPGP |
Common Stock |
Options Exercise |
$39,879 |
+629 |
+3.8% |
$63.40 |
17,120 |
30 Jan 2024 |
Direct |
|
| transaction |
IPGP |
Common Stock |
Sale |
$62,900 |
-629 |
-3.7% |
$100.00 |
16,491 |
30 Jan 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IPGP |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-813 |
-21% |
$0.000000 |
2,987 |
29 Jan 2024 |
Common Stock |
813 |
$63.40 |
Direct |
F4 |
| transaction |
IPGP |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-629 |
-21% |
$0.000000 |
2,358 |
30 Jan 2024 |
Common Stock |
629 |
$63.40 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: